[HTML][HTML] Update on fibroblast growth factor 23 in chronic kidney disease

M Wolf - Kidney international, 2012 - Elsevier
Chronic kidney disease (CKD) is a public health epidemic that affects millions of people
worldwide. Presence of CKD predisposes individuals to high risks of end-stage renal …

Cardiac calcification in adult hemodialysis patients: a link between end-stage renal disease and cardiovascular disease?

P Raggi, A Boulay, S Chasan-Taber, N Amin… - Journal of the American …, 2002 - jacc.org
Objectives: We sought to determine clinical and laboratory correlates of calcification of the
coronary arteries (CAs), aorta and mitral and aortic valves in adult subjects with end-stage …

ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in …

P Greenland, RO Bonow, BH Brundage… - Journal of the American …, 2007 - jacc.org
Summary...... 387 Role of CAC Scoring in Assessment of Symptomatic Patients...... 388
Diagnosis of Coronary Stenosis in Patients With Possible CHD by CAC...... 388 Comparison …

[HTML][HTML] Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

GM Chertow, SK Burke, P Raggi… - Kidney international, 2002 - Elsevier
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis
patients. Background Cardiovascular disease is frequent and severe in patients with end …

Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a …

JL Reynolds, AJ Joannides, JN Skepper… - Journal of the …, 2004 - journals.lww.com
Patients with ESRD have a high circulating calcium (Ca)× phosphate (P) product and
develop extensive vascular calcification that may contribute to their high cardiovascular …

Association of elevated serum PO4, Ca× PO4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients

SK Ganesh, AG Stack, NW Levin… - Journal of the …, 2001 - journals.lww.com
Hyperphosphatemia is highly prevalent among patients with end-stage renal disease
(ESRD) and is associated with increased mortality risk in hemodialysis (HD) patients. The …

The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification

C Schäfer, A Heiss, A Schwarz… - The Journal of …, 2003 - Am Soc Clin Investig
Ectopic calcification is a frequent complication of many degenerative diseases. Here we
identify the serum protein α2–Heremans-Schmid glycoprotein (Ahsg, also known as fetuin …

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis

GA Block, KJ Martin, ALM De Francisco… - … England Journal of …, 2004 - Mass Medical Soc
Background Treatment of secondary hyperparathyroidism with vitamin D and calcium in
patients receiving dialysis is often complicated by hypercalcemia and hyperphosphatemia …

Vascular calcification: the killer of patients with chronic kidney disease

M Mizobuchi, D Towler… - Journal of the American …, 2009 - journals.lww.com
Cardiovascular complications are the leading cause of death in patients with chronic kidney
disease (CKD). Vascular calcification is a common complication in CKD, and investigators …

[HTML][HTML] Fibroblast growth factor 23 is not associated with and does not induce arterial calcification

JJ Scialla, WL Lau, MP Reilly, T Isakova, HY Yang… - Kidney international, 2013 - Elsevier
Elevated fibroblast growth factor 23 (FGF23) is associated with cardiovascular disease in
patients with chronic kidney disease. As a potential mediating mechanism, FGF23 induces …